RecruitingNCT03291652
Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential
Sponsor
Chinese University of Hong Kong
Enrollment
140 participants
Start Date
Feb 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
The study is to attain early recognition of the unstable plaques which have an imminent embolic risk in patients with intracranial atherosclerotic disease (IAD).
Eligibility
Min Age: 30 YearsMax Age: 85 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying DSA/3DRA for people with atheroscleroses, cerebral and ischemic stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 85 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTDSA/3DRA
DSA/3DRA
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03291652
Related Trials
Head of Bed After Ischemic Stroke Thrombectomy (HoBIT)
NCT07367633
Change in Serum Biomarkers After Endovascular Treatment for Acute Anterior Circulation Large Vessel Occlusion
NCT063831821 location
Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke
NCT069315351 location
Head dOwn Position Before Endovascular Treatment for Large veSsel Occlusion (HOPES5)
NCT071727891 location
Repetitive Transcranial Magnetic Stimulation for Motor Recovery After Ischemic Stroke (rTMS-MOTOR)
NCT07369648